Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Rising demand for premium, clean-label, and vegan supplements
November 14, 2025
Paxlovid (nirmatrelvir/ritonavir) Disease area(s): Infectious diseases (antivirals) Manufacturer(s): Pfizer 2024 Sales (USD): $5.72 billion Why it sold so well: In 2024, Pfizers COVID-19 antiviral treatment, Paxlovid, generated $5.72 billion in global revenue, making it the companys third-highest-selling product for the year
1, 2024, and now also applies to EmblemHealth commercial members as well
US$ 28.20
US$ 25.29
US$ 21.27
US$ 28.81
US$ 27.26
US$ 27.82
US$ 28.09
US$ 25.41
